Return to CBI Antibody Core Home Page
  Return to biothreat/emerging pathogens list
    Return to typhus (Breinel strain) (Exanthematous typhus) ( Rickettsia prowazekii ) list


typhus (Breinel strain) (Exanthematous typhus) ( Rickettsia prowazekii )
Rp. ompB


Antibody Name/Abbreviation: Rp. ompB
CBI Antibody Core Code: A1455

"Lot" Number: 1 Position: 95 (1548-1643)
% Identical Homology of Target to Mouse Protein: 27% (NP_032197.2| glutamate receptor, ionotropic, NMDA2B (epsilon 2); GluRepsilon2)
Molecular Weight of fusion protein: 24.56 KDa

Target sequence used to make this antibody:
VAGSTVNITDIVIYPEIHSFVVHKVNGKLSNSQSMLDGQT
APFISQPDRTAKTSYNIGLSANIKSDAKMEYGIGYDFNSA
SKYTAHQGTLKVRVNF






Sequence Name: Rp. ompB
Full name: Rickettsia outer membrane protein B
UniGene Number: N.A.
Accession Number: AF161079
Source organism: typhus (Breinel strain) (Exanthematous typhus) ( Rickettsia prowazekii )
Full length size (aa): 1643
NCBI information page: click here

Full length sequence:
MAQKPNFLKKIISAGLVTASTATIVAGFSGVAMGAAMQYNRTTNAAATTF
DGIGFDQAAGANIPVAPNSVITANANNPITFNTPNGHLNSLFLDTANDLA
VTINEDTTLGFITNIAQQAKFFNFTVAAGKILNITGQGITVQEASNTINA
QNALTKVHGGAAINANDLSGLGSITFAAAPSVLEFNLINPTTQEAPLTLG
ANSKIVNGGNGTLNITNGFIQVSDNTFAGIKTINIDDCQGLMFNSTPDAA
NTLNLQAGGNTINFNGIDGTGKLVLVSKNGAATEFNVTGTLGGNLKGIIE
LNTAAVAGKLISQGGAANAVIGTDNGAGRAAGFIVSVDNGNAATISGQVY
AKNMVIQSANAGGQVTFEHIVDVGLGGTTNFKTADSKVIITENSNFGSTN
FGNLDTQIVVPDTKILKGNFIGDVKNNGNTAGVITFNANGALVSASTDPN
IAVTNINAIEAEGAGVVELSGIHIAELRLGNGGSIFKLADGTVINGPVNQ
NALMNNNALAAGSIQLDGSAIITGDIGNGGVNAALQHITLANDASKILAL
DGANIIGANVGGAIHFQANGGTIKLTNTQNNIVVNFDLDITTDKTGVVDA
SSLTNNQTLTINGSIGTVVANTKTLAQLNIGSSKTILNAGDVAINELVIE
NNGSVQLNHNTYLITKTINAANQGQIIVAADPLNTNTTLADGTNLGSAEN
PLSTIHFATKAANADSILNVGKGVNLYANNITTNDANVGSLHFRSGGTSI
VSGTVGGQQGHKLNNLILDNGTTVKFLGDTTFNGGTKIEGKSILQISNNY
TTDHVESADNTGTLEFVNTDPITVTLNKQGAYFGVLKQVIISGPGNIVFN
EIGNVGIVHGIAANSISFENASLGTSLFLPSGTPLDVLTIKSTVGNGTVD
NFNAPIVVVSGIDSMINNGQIIGDKKNIIALSLGSDNSITVNANTLYSGI
RTTKNNQGTVTLSGGMPNNPGTIYGLGLENGSPKLKQVTFTTDYNNLGSI
IANNVTINDDVTLTTGGIAGTDFDAKITLGSVNGNANVRFVDSTFSDPRS
MIVATQANKGTVTYLGNALVSNIGSLDTPVASVRFTGNDSGAGLQGNIYS
QNIGFGTYNLTILNSNVILGGGSTAINGEIDLLTNNLIFANGTSTWGDNT
SISTTLNVSSGNIGQVVIAEDAQVNATTTGTTTIKIQDNANANFSGTQAY
TLIQGGARFNGTLGAPNFAVTGSNIFVKYELIRDSNQDYVLTRTNDVLNV
VTTAVGNSAIANAPGVSQNISRCLESTNTAAYNNMLLAKDPSDVATFVGA
IATDTSAAVTTVNLNDTQKTQDLLSNRLGTLRYLSNAETSDVAGSATGAV
SSGDEAEVSYGVWAKPFYNIAEQDKKGGIAGYKAKTTGVVVGLDTLASDN
LMIGAAIGITKTDIKHQDYKKGDKTDINGLSFSLYGSQQLVKNFFAQGNS
IFTLNKVKSKSQRYFFESNGKMSKQIAAGNYDNMTFGGNLIFGYDYNAMP
NVLVTPMAGLSYLKSSNENYKETGTTVANKRINSKFSDRVDLIVGAKVAG
STVNITDIVIYPEIHSFVVHKVNGKLSNSQSMLDGQTAPFISQPDRTAKT
SYNIGLSANIKSDAKMEYGIGYDFNSASKYTAHQGTLKVRVNF





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.